![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.europeanpharmaceuticalreview.com/news/231638/generic-hiv-raltegravir-medicines-approved/
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-raltegravir-potassium-tablets-92868.pdf
https://www.fiercepharma.com/pharma/roche-merck-novartis-and-others-raise-prices-83-meds-to-start-july-analyst?utm_source=internal&utm_medium=rss
http://www.fiercepharma.com/pharma/merck-shops-for-hefty-m-a-amid-uninspiring-q1-for-new-meds
http://www.fiercepharmamarketing.com/story/glaxosmithklines-hiv-bright-spot-could-get-brighter-new-tivicay-combo-meds/2015-11-04
http://www.philly.com/philly/business/20150224_ap_fe9549f6f2854dad9accaf0e8033a2c4.html